financetom
Business
financetom
/
Business
/
--Qualcomm Keeps Quarterly Dividend at $0.85 per Share, Payable Dec. 19 to Shareholders of Record on Dec. 5
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
--Qualcomm Keeps Quarterly Dividend at $0.85 per Share, Payable Dec. 19 to Shareholders of Record on Dec. 5
Oct 17, 2024 1:30 PM

09:29 AM EDT, 10/16/2024 (MT Newswires) --

Price: 174.70, Change: +0.61, Percent Change: +0.35

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Factbox-Trump's tariffs: What's in effect and what could be in store?
Factbox-Trump's tariffs: What's in effect and what could be in store?
Jul 16, 2025
WASHINGTON (Reuters) -U.S. President Donald Trump has launched a global trade war with an array of tariffs that target individual products and countries.  Trump has set a baseline tariff of 10% on all imports to the United States, as well as additional duties on certain products or countries.  Here is a list of targeted tariffs he has implemented or threatened...
Johnson & Johnson Lifts 2025 Outlook as Second-Quarter Results Top Street Views
Johnson & Johnson Lifts 2025 Outlook as Second-Quarter Results Top Street Views
Jul 16, 2025
09:11 AM EDT, 07/16/2025 (MT Newswires) -- Johnson & Johnson ( JNJ ) raised its full-year outlook on Wednesday as the healthcare products conglomerate recorded better-than-expected second-quarter results, amid double-digit gains from sales of its oncology and cardiovascular products. The company now expects adjusted earnings to come in between $10.80 and $10.90 per share for 2025, up from its previous...
FDA staff raises efficacy concerns for Otsuka's PTSD combination drug
FDA staff raises efficacy concerns for Otsuka's PTSD combination drug
Jul 16, 2025
July 16 (Reuters) - The U.S. Food and Drug Administration's staff reviewers on Wednesday raised efficacy concerns over Otsuka Pharma's combination treatment for adults with post-traumatic stress disorder (PTSD), citing inconsistent trial results and a modest treatment effect that may not be clinically meaningful. ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved